Status:
COMPLETED
Research of Biomarkers in Parkinson Disease
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsors:
European Union
Conditions:
Parkinson Disease
Multiple System Atrophy
Eligibility:
All Genders
18-90 years
Brief Summary
The main goal of the GENEPARK consortium is to employ innovative haemogenomic approaches to determine gene expression profiles specific for genetic and idiopathic Parkinson's disease (PD) patients. Th...
Detailed Description
Employ innovative haemogenomic approaches to determine gene expression signatures specific for idiopathic Parkinson's disease (PD). There is currently no specific clinical or laboratory diagnostic tes...
Eligibility Criteria
Inclusion
- Diagnosis of Parkinson's disease
- Ability to understand the aim of the study
- Ability to sign the consent form
Exclusion
- Non ability to understand the aim of the study
- Non ability to sign the consent form
- To be over 18
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT00465790
Start Date
October 1 2007
End Date
June 1 2012
Last Update
September 27 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Meditterranean Institute for Life Sciences
Split, Croatia
2
INSERM Unit 679
Paris, France, 75013
3
University of Lübeck and Neuroimage Nord
Lübeck, Germany
4
University Hospital Tübingen
Tübingen, Germany